42 related articles for article (PubMed ID: 7678643)
1. Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement.
Clin B; ; Pairon JC
BMC Public Health; 2014 Nov; 14():1155. PubMed ID: 25377503
[TBL] [Abstract][Full Text] [Related]
2. A work-relatedness assessment in epidemiological case investigation of occupational cancers: II. Practice: an upper urinary tract cancer in a dyer.
Kim K; Oh H; Kim J
Ann Occup Environ Med; 2020; 32():e31. PubMed ID: 33072342
[TBL] [Abstract][Full Text] [Related]
3. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts.
Rothman N; Hayes RB; Zenser TV; DeMarini DM; Bi W; Hirvonen A; Talaska G; Bhatnagar VK; Caporaso NE; Brooks LR; Lakshmi VM; Feng P; Kashyap SK; You X; Eischen BT; Kashyap R; Shelton ML; Hsu FF; Jaeger M; Parikh DJ; Davis BB; Yin S; Bell DA
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):979-83. PubMed ID: 8959320
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism in the N-acetyltransferase 1 alleles NAT1*10 and NAT1*14A and cytological gradings of exfoliated urothelial cells in benzidine-exposed Chinese workers: discussion of ethnic differences.
Guo WC; Lin GF; Chen JG; Golka K; Shen JH
Arch Toxicol; 2004 Aug; 78(8):425-9. PubMed ID: 15197537
[TBL] [Abstract][Full Text] [Related]
5. The Drake Health Registry Study: findings from fifteen years of continuous bladder cancer screening.
Marsh GM; Cassidy LD
Am J Ind Med; 2003 Feb; 43(2):142-8. PubMed ID: 12541268
[TBL] [Abstract][Full Text] [Related]
6. Early results of bladder-cancer screening in a high-risk population of heavy smokers.
Steiner H; Bergmeister M; Verdorfer I; Granig T; Mikuz G; Bartsch G; Stoehr B; Brunner A
BJU Int; 2008 Aug; 102(3):291-6. PubMed ID: 18336612
[TBL] [Abstract][Full Text] [Related]
7. Field molecular epidemiology. Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort.
Bi W; Rao JY; Hemstreet GP; Fang P; Asal NR; Zang M; Min KW; Ma Z; Lee E; Li G
J Occup Med; 1993 Jan; 35(1):20-7. PubMed ID: 7678643
[TBL] [Abstract][Full Text] [Related]
8. Quantitative fluorescence image analysis in bladder cancer screening.
Hemstreet GP; Hurst RE; Bass RA; Rao JY
J Occup Med; 1990 Sep; 32(9):822-8. PubMed ID: 2074505
[TBL] [Abstract][Full Text] [Related]
9. G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials.
Hemstreet GP; Rao J; Hurst RE; Bonner RB; Waliszewski P; Grossman HB; Liebert M; Bane BL
J Cell Biochem Suppl; 1996; 25():197-204. PubMed ID: 9027619
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of biological tumor markers for early detection of neoplastic changes in the bladder of persons exposed to aromatic amines].
Hanke J; Krajewska B; Lutz W
Med Pr; 1989; 40(6):376-80. PubMed ID: 2698439
[TBL] [Abstract][Full Text] [Related]
11. Oncogene proteins as molecular epidemiologic markers of cancer risk in hazardous waste workers.
Brandt-Rauf P
Occup Med; 1990; 5(1):59-65. PubMed ID: 2137261
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
